Citations

Showing 10 of 108094 citations.

Mechano-Sensing Channel PIEZO2 Enhances Invasive Phenotype in Triple-Negative Breast Cancer
Katsuta, Eriko , Takabe, Kazuaki , Vujcic, Marija, Dai, Tao , Mercado‐Perez, Arnaldo , Beyder, Arthur, Wang, Qingfei , Opyrchal, Mateusz , Mercado-Perez, Arnaldo, Wang, Qingfei , Opyrchal, Mateusz , Gottlieb, Philip A.

Mayo Clinic

International Journal of Molecular Sciences | September 1, 2022 | Volume: 23 | Issue: 17 | Pages: 9909

10.3390/ijms23179909 | PMID 36077309 Get It

Background: Mechanically gated PIEZO channels lead to an influx of cations, activation of additional Ca2+ channels, and cell depolarization. This study aimed to investigate PIEZO2’s role in breast cancer. Methods: The clinical relevance of PIEZO2 expression in breast cancer patient was analyzed in a publicly available dataset. Utilizing PIEZO2 overexpressed breast cancer cells, and in vitro and in vivo experiments were conducted. Results: High expression of PIEZO2 was correlated with a worse survival in triple-negative breast cancer (TNBC) but not in other subtypes. Increased PEIZO2 channel function was confirmed in PIEZO2 overexpressed cells after mechanical stimulation. PIEZO2 overexpressed cells showed increased motility and invasive phenotypes as well as higher expression of SNAIL and Vimentin and lower expression of E-cadherin in TNBC cells. Correspondingly, high expression of PIEZO2 was correlated with the increased expression of epithelial–mesenchymal transition (EMT)-related genes in a TNBC patient. Activated Akt signaling was observed in PIEZO2 overexpressed TNBC cells. PIEZO2 overexpressed MDA-MB-231 cells formed a significantly higher number of lung metastases after orthotopic implantation. Conclusion: PIEZO2 activation led to enhanced SNAIL stabilization through Akt activation. It enhanced Vimentin and repressed E-cadherin transcription, resulting in increased metastatic potential and poor clinical outcomes in TNBC patients.
Risk Factors for Reduced Function in Women with a History of Breast Cancer
Stoyles, Nicholas, Zucker, David J. , Richards, Blair , Vargo, Mary , Shahpar, Samman , Henderson, Maryanne, Jay, Gina , Smith, Sean R. , Cheville, Andrea , Zucker, David, Gerber, Lynn H.

Mayo Clinic

No container title available | September 1, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1987491/v1 Get It

Abstract Purpose Breast cancer patients are at risk of losing function during and after treatment. Unfortunately, little is known about the individual and additive effects of specific treatment, disease-related, and demographic factors that may contribute to functional decline. This manuscript reports the results of a multi-center study to evaluate the effects of these factors on function. Methods In this cross-sectional study, women with a history of breast cancer referred to cancer rehabilitation clinics were administered the PROMIS Cancer Function Brief 3D Profile to evaluate function in the domains of physical function, fatigue, and social participation. Clinical and demographic information, including treatment history and disease status, was recorded by clinicians. Patients were analyzed in two groups: those with active disease on antineoplastic treatment, and those with no evidence of disease (NED). A multivariable model was constructed to detect associations between clinical and demographic factors. Results In patients with NED, the presence of chemotherapy-induced peripheral neuropathy (CIPN) was strongly associated with reduced function in all three domains. In those with active disease, having brain metastases was significantly associated with reduced function in all domains and CIPN with reduced physical function. Radiation was associated with improved function in both cohorts. Conclusions Among women seeking rehabilitative care, CIPN and the presence of brain metastases were most strongly associated with a decline in function. The effects of radiation on function were unexpected and may be partially explained by the treatment’s role in symptom management. Clinicians who treat breast cancer should consider a patient’s functional status when providing supportive care.
Safety and Efficacy of Transoral Robotic Thyroidectomy for Thyroid Tumor: A Systematic Review and Meta-Analysis
Kang, Yun Jin , Cho, Jinhee , Stybayeva, Gulnaz, Hwang, Se Hwan , Hwang, Se Hwan , Stybayeva, Gulnaz

Mayo Clinic

Cancers | August 31, 2022 | Volume: 14 | Issue: 17 | Pages: 4230

10.3390/cancers14174230 | PMID 36077768 Get It

Background: To assess the safety and effectiveness of transoral robotic thyroidectomy (TORT) in thyroid tumor. Methods: PubMed, Embase, Web of Science, SCOPUS, Cochrane database, and Google Scholar up to June 2022. Studies comparing outcomes and complications between TORT and control groups (robotic bilateral axillo-breast, trans-axillary, postauricular approach, conventional open thyroidectomy (OT), and transoral endoscopic approach) were analyzed. Results: Ten studies of 1420 individuals. The operative time (SMD 1.15, 95%CI [0.48; 1.89]) was significantly longer and the number of retrieved lymph nodes (LNs) (SMD −0.27, 95%CI [−0.39; −0.16]) was fewer in TORT than in the control group. The postoperative cosmetic satisfaction score (SMD 0.60, 95%CI [0.28; 0.92]) was statistically higher in TORT than in the control group. In subgroup analysis, there was no significant difference between robotic surgeries. However, TORT had significantly longer operative times (SMD 2.08, 95%CI [0.95; 3.20]) and fewer retrieved LNs (SMD −0.32, 95%CI [−0.46; −0.17]) than OT. TORT satisfied significantly more patients in cosmetic view. However, it increased hospitalization days and postoperative pain on the operation day and first day compared to OT. Conclusions: TORT is not inferior to other robotic-assisted approaches. Its operation time and hospitalization days are longer and postoperative pain is greater than OT, although its cosmetic satisfaction is high.
Skull Base Registries: A Roadmap
Parikh, Kara P., Beer‐Furlan, André , Michael, L. Madison, Rangarajan, Sanjeet V., Kshettry, Varun R. , Saleh, Sara , Mukherjee, Debraj , Kirsch, Claudia , Sorenson, Jeffrey, Choby, Garret W, Saleh, Sara , Kirsch, Claudia , Mukherjee, Debraj , Parikh, Kara A. , Motiwala, Mustafa , Michael, Lattimore Madison , Choby, Garret , McKean, Erin L.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | August 31, 2022 | Volume: 83 | Issue: 06 | Pages: 561-578

10.1055/a-1934-9191 | PMID 36393883 Get It

AbstractHospitals, payors, and patients increasingly expect us to report our outcomes in more detail and to justify our treatment decisions and costs. Although there are many stakeholders in surgical outcomes, physicians must take the lead role in defining how outcomes are assessed. Skull base lesions interact with surrounding anatomy to produce a complex spectrum of presentations and surgical challenges, requiring a wide variety of surgical approaches. Moreover, many skull base lesions are relatively rare. These factors and others often preclude the use of prospective randomized clinical trials, thus necessitating alternate methods of scientific inquiry. In this paper, we propose a roadmap for implementing a skull base registry, along with expected benefits and challenges.
Stereotactic Radiosurgery Outcomes in Medically and Surgically Failed or Nonsurgical Candidates with Medically Failed Prolactinomas: A Systematic Review and Meta-Analysis
Yagnik, Karan J. , Erickson, Dana , Laack, Nadia N., Gompel, Jamie J. Van , Van Gompel, Jamie J , Bancos, Irina , Choby, Garret

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | August 31, 2022 | Volume: 84 | Issue: 06 | Pages: 538-547

10.1055/a-1934-9028 | PMID 37854534 Get It

Abstract Objective Prolactinomas are treated with dopamine agonists (DAs) as first-line therapy and transsphenoidal surgery as an alternative approach for medically failed tumors. We sought to summarize the efficacy of stereotactic radiosurgery (SRS) in the medically and surgically failed prolactinomas as well as in nonsurgical candidates with medically failed prolactinomas by systematic review and meta-analysis. Method A literature search was conducted according to the Preferred Reporting Items for Systematic Review and Meta-Analyses guideline. Results A total of 11 articles (total N = 709) met inclusion criteria. Thirty-three percent of patients were able to achieve endocrine remission at a mean follow-up of 54.2 ± 42.2 months with no association between stopping DA and endocrine remission. Sixty-two percent of patients were able to achieve endocrine control with DA therapy and 34% of patients were able to decrease the dose of DA dose when compared with pre-SRS DA dose at the end of the follow-up period. However, 54% of patients required DA at the end of the follow-up to control hyperprolactinemia. Ninety percent of patients were able to achieve radiologic control at the end of the follow-up in comparison to pre-SRS imagings. Furthermore, 26% of patients newly developed hypopituitarism (one or more pituitary hormones) post-SRS throughout the follow-up period. Conclusion This systematic review and meta-analysis demonstrates SRS as an effective adjunct therapy in medically failed nonsurgical candidates or surgically and medically recalcitrant prolactinomas with a 33% chance of achieving endocrine remission, 62% of patients achieved hormonal control with DA and GKRS (gamma knife radio-surgery), with a 34% chance of decreasing DA dose and 90% chance of achieving radiologic control.
Cardiac Rehabilitation Completion Study: Barriers and Potential Solutions
Supervía, Marta , Medina‐Inojosa, José R. , Martínez‐Jarreta, Begoña , Lopez‐Jimenez, Francisco, Vickers, Kristen, Terzic, Carmen M., Medina-inojosa, Jose, Medina-Inojosa, José R , López-Jiménez, Francisco , Thomas, Randal J.

Mayo Clinic

Journal of Cardiopulmonary Rehabilitation and Prevention | August 31, 2022 | Volume: 42 | Issue: 5 | Pages: 375-377

10.1097/hcr.0000000000000709 | PMID 36044761 Get It

Sulfotransferase (sult) 1A1 pharmacogenetics: Functional 5′‐flanking region (5′‐FR) polymorphisms
Prondzinski, Janel L, Thomae, Bianca A., Wang, L., Eckloff, Bruce W., Wieben, Eric D. , Weinshilboum, Richard

Mayo Clinic

Clinical Pharmacology & Therapeutics | August 31, 2022 | Volume: 73 | Issue: 2 | Pages: No page available

10.1016/s0009-9236(03)90641-2b Get It

Clinical Pharmacology & Therapeutics (2003) 73, P77–P77; doi:
Burnout in Diplomates of the American Board of Physical Medicine and Rehabilitation—Prevalence and Potential Drivers: A Prospective Cross‐Sectional Survey
Sliwa, James A. , Clark, Gary S., Chiodo, Anthony E., Kinney, Carolyn L. , Raddatz, Mikaela M. , Micheo, William , Robinson, Lawrence R. , Robinson, Lawrence R , Kinney, Carolyn , Francisco, Gerard E.

Mayo Clinic

PM&R | August 31, 2022 | Volume: 11 | Issue: 1 | Pages: 83-89

10.1016/j.pmrj.2018.07.013 | PMID 30703291 Get It

Background Physician burnout is of growing concern. Burnout among physical medicine and rehabilitation (PM&R) physicians has shown a significant increase, positioning PM&R as one of the most “burned out” of specialties. Little has been written about potential factors contributing to physiatrist burnout or potential interventions. Objective To determine the prevalence of burnout among physiatrists and identify risk factors for burnout and potential strategies to decrease burnout among physiatrists. Design Prospective cross‐sectional survey. Setting National survey of board certified physiatrists. Participants: One thousand five hundred thirty‐six physiatrists certified by the American Board of PM&R. Outcome The Mini‐Z Burnout Survey, 1 question from the Maslach Burnout Scale on callousness toward patients, and several potential drivers of burnout. The probability of burnout, identified by question 3 on the Mini‐Z, was the dependent variable. Other questions on the Mini‐Z were explored as independent variables using logistic regression. Results Seven hundred seventy physiatrists (50.7%) fulfilled the definition of burnout. Only 38% of physiatrists reported not becoming more callous toward patients. The top 3 causes of burnout identified by physiatrists were increasing regulatory demands, workload and job demands, and practice inefficiency and lack of resources. Higher burnout rate was associated with high levels of job stress and working more hours per week. Lower burnout rates were associated with higher job satisfaction, control over workload, professional values aligned with those of department leaders, and sufficient time for documentation. There was no significant association between burnout and sex, years in practice, practice focus, or practice area. Conclusion Burnout is a significant problem among PM&R physicians and is pervasive throughout the specialty. Opportunities exist to address major contributing drivers of burnout relating to practice patterns and efficiency of care within PM&R. These opportunities are, to varying degrees, under the control of hospital leaders, practice administrators, and practitioners.
Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants
Murphy, Richard, Sahiar, Farhad, Ingall, Timothy J., Dhamane, Amol D., Ferri, Mauricio , Hlavacek, Patrick , Preib, Madison T , Keshishian, Allison , Russ, Cristina , Rosenblatt, Lisa, Deitelzweig, Steven , Lip, Gregory Y H , Yüce, Hüseyin

Mayo Clinic

JAMA Network Open | August 31, 2022 | Volume: 5 | Issue: 8 | Pages: e2229333

10.1001/jamanetworkopen.2022.29333 | PMID 36044214 Get It

Analysis of Sex and Gender Reporting Policies in Preeminent Biomedical Journals
Bibb, Lorin A. , Adkins, Brian D. , Booth, Garrett S. , Shelton, K. Maureen, Jacobs, Jeremy W. , Jacobs, Jeremy W , Booth, Garrett , Adkins, Brian David

Mayo Clinic

JAMA Network Open | August 31, 2022 | Volume: 5 | Issue: 8 | Pages: e2230277

10.1001/jamanetworkopen.2022.30277 | PMID 36044219 Get It